CVS Caremark, Generation Health to Expand PGx Testing to Millions | GenomeWeb

NEW YORK (GenomeWeb News) – CVS Caremark the country’s largest pharmacy services provider, has decided to expand pharmacogenomic testing to its pharmacy benefit management customers to predict their responses to treatments for cancer, cardiovascular diseases, and HIV.

Generation Health, a company launched last year to help insurers, employers, and PBMs implement genetic testing with their systems, will help CVS Caremark put its pharmacogenomics testing programs in place, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.